Observational studyBMJ mental health2025
Increasing incidence of ADHD among children, adolescents and young adults: COVID-19 pandemic-driven trend in Korea (2012-2023).
Observational study in BMJ mental health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe association between the incidence of attention deficit hyperactivity disorder (ADHD) and the factors induced by the COVID-19 pandemic has not been fully investigated. Environmental stressors during or after the pandemic, including online classes and lifestyle disruptions, and postinfection neuroimmune changes likely contributed to the increase of ADHD.
methodsThe onset of ADHD was operationally defined as the diagnosis accompanied by a prescription history for ADHD medication. The incidence was observed among all Korean citizens (6-29 years). To evaluate the risk of ADHD, we established a retrospective and observational cohort, using data from the National Insurance Claims Database, the COVID-19 Vaccine Registry and the national surveillance system to find the patient. Our cohort (586 860 and 1 172 735 participants before and during the pandemic, respectively) comprised three age groups: school-aged children (6-12 years, n=227 276), adolescents (13-19 years, n=333 032) and young adults (20-29 years, n=1 199 287); sex ratio (male/female) was approximately 1.2.
resultsWe analysed the incidence of ADHD in Korea (2012-2023), focusing on the COVID-19 pandemic's impact on individuals. The incidence of ADHD increased during the pandemic, exceeding values predicted by negative binomial regression and autoregressive integrated moving average models. We also evaluated the risk of ADHD according to SARS-CoV-2 infection. As a result, these nationwide data revealed a significant rise in incidence (0.85 (before) vs 2.02 (during)), with SARS-CoV-2 infection identified as a critical risk factor.
conclusionThese findings suggest the need for early intervention and neurological evaluations in ADHD risk groups, particularly among SARS-CoV-2-infected individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.